Multicentric Castleman's disease developing during follow-up of sarcoidosis

被引:2
|
作者
Sawata, Tetsuro [1 ]
Bando, Masashi [1 ]
Nakayama, Masayuki [1 ]
Mato, Naoko [1 ]
Takemura, Tamiko [2 ]
Sugiyama, Yukihiko [1 ]
机构
[1] Jichi Med Univ, Dept Med, Div Pulm Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan
来源
RESPIROLOGY CASE REPORTS | 2016年 / 4卷 / 04期
关键词
Interleukin-6; multicentric Castleman's disease; sarcoidosis; thoracoscopic lung biopsy;
D O I
10.1002/rcr2.168
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary sarcoidosis is reported to have complication of lymphoproliferative disease such as malignant lymphoma, but the complication of multicentric Castleman's disease (MCD) is rarely reported. In our case of a 60-year-old woman, bilateral hilar lymphadenopathy was noted in her chest X-ray. We performed a transbronchial lung biopsy. She was diagnosed as having pulmonary sarcoidosis (Stage II). The shadow on chest X-ray disappeared without treatment. However, after 8 years, swelling of the mediastinal and abdominal lymph node, thickened bronchovascular bundle, and multiple nodular shadows were identified, and a thoracoscopic lung biopsy was performed. Based on the histopathological findings and elevated serum interleukin-6 level (75.7 pg/mL), she was diagnosed with pulmonary sarcoidosis complicated byMCD. When a change in chest X-ray findings are found during monitoring of pulmonary sarcoidosis, it is important to proceed with a thoracoscopic lung biopsy, because of the possibility of the rare complication of MCD.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Apoptosis of T cells in multicentric Castleman's disease
    Ishiyama, T
    Koike, M
    Fukuchi, K
    Tomoyasu, S
    Yoshida, M
    Wakabayashi, Y
    Tsuruoka, N
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 79 (03): : 271 - 277
  • [32] Retinoic acid for treatment of multicentric Castleman's disease
    Rieu, P
    Droz, D
    Gessain, A
    Grünfeld, JP
    Hermine, O
    LANCET, 1999, 354 (9186): : 1262 - 1263
  • [33] HIV-associated multicentric Castleman's disease
    Stebbing, Justin
    Pantanowitz, Liron
    Dayyani, Farshid
    Sullivan, Ryan J.
    Bower, Mark
    Dezube, Bruce J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (06) : 498 - 503
  • [34] Multicentric Castleman's disease in a child with subpectoral involvement
    Polat Koşucu
    Ali Ahmetoğlu
    Mustafa İmamoğlu
    Ali Çay
    Ümit Çobanoğlu
    Halit Reşit Gümele
    Pediatric Radiology, 2003, 33 : 570 - 573
  • [35] Case of hepatocellular carcinoma with multicentric Castleman's disease
    Cheung, Yue-Sun
    Chan, Anthony Wing-Hung
    Lee, Kit-Fai
    Wong, John
    Chong, Charing Ching-Ning
    Lai, Paul Bo-San
    SURGICAL PRACTICE, 2014, 18 (03) : 154 - 155
  • [36] Multicentric Castleman's Disease: An Emerging Opportunistic Infection
    McCall, Jane
    Phillips, J. Craig
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2013, 24 (01): : 88 - 90
  • [37] NOVEL TREATMENT OF MULTICENTRIC CASTLEMAN'S DISEASE WITH LENALIDOMIDE
    Krawczyk, J.
    Murphy, T.
    Swords, R.
    Meenaghan, T.
    O'Dwyer, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 495 - 495
  • [38] Exploiting interleukin 6 in multicentric Castleman's disease
    Bower, Mark
    Stebbing, Justin
    LANCET ONCOLOGY, 2014, 15 (09): : 910 - 912
  • [39] Multicentric Castleman's disease presenting with cutaneous plasmacytosis
    Phadungsaksawasdi, Pawit
    Nakazawa, Shinsuke
    Kageyama, Reiko
    Tokura, Yoshiki
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2020, 3 (04) : 86 - 87
  • [40] Dose selection of siltuximab for multicentric Castleman's disease
    Mayer, Christina L.
    Xie, Lanyi
    Bandekar, Rajesh
    Qi, Ming
    van de Velde, Helgi
    Reddy, Manjula
    Qin, Xiang
    Davis, Hugh M.
    Puchalski, Thomas A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 1037 - 1045